• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT
Click for more information
1.37% 7.2¢

BIOTRON LIMITED

Market Cap $64.96M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BIT
BIT036- a likely candidate for curing COVID-19
30 31 32
01:29 1.8K 661K
01:29 Last post  caspex Comments Created with Sketch.  1.8K  Views Created with Sketch.  661K 
BIT
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
3 4 5
16/04/24 290 87K
16/04/24 Last post  Umbriel Comments Created with Sketch.  290  Views Created with Sketch.  87K 
BIT
BIT Chart 		16/04/24 18 3.0K
16/04/24 Last post  zyw102456 Comments Created with Sketch.  18  Views Created with Sketch.  3.0K 
BIT
$30 Billion Deal
81 82 83
12/04/24 4.9K 1.3M
12/04/24 Last post  Scooterdog Comments Created with Sketch.  4.9K  Views Created with Sketch.  1.3M 
BIT
HYPED UP TO THE MAX
2
12/04/24 84 18K
12/04/24 Last post  Batmansdaughter Comments Created with Sketch.  84  Views Created with Sketch.  18K 
BIT
BIT Charting
23 24 25
10/04/24 1.4K 415K
10/04/24 Last post  $$$$$$$$ Comments Created with Sketch.  1.4K  Views Created with Sketch.  415K 
BIT
$10 Billion Deal
206 207 208
08/04/24 12K 6.1M
08/04/24 Last post  Fingers xed Comments Created with Sketch.  12K  Views Created with Sketch.  6.1M 
BIT
BIRD FLU 		08/04/24 3 1.0K
08/04/24 Last post  $$$$$$$$ Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Timeline

POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
05 Apr 09:38
 
Response to ASX Price Query
27 Mar 09:05
 
Half Yearly Report and Accounts
27 Feb 09:06
 
$1.64M R&D rebate received
08 Feb 13:00
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 09:55
 
Shareholder Update
14 Dec 09:57
 
View More arrow Created with Sketch.

Featured News

RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
FXG Market purrs with approval of Felix's 90% gold recovery in Alaska
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.
BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
(20min delay)
Last
7.2¢ 		Change
-0.001(1.37%) 		Mkt cap ! $64.96M
Open High Low Value Volume
7.6¢ 7.6¢ 7.1¢ $56.77K 777.6K

Buyers (Bids)

No. Vol. Price($)
1 40000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 10000 1
View Market Depth
Last trade - 15.03pm 16/04/2024 (20 minute delay) ?
Last
7.2¢ 		  Change
-0.001 ( 2.70 %)
Open High Low Volume
7.4¢ 7.4¢ 7.2¢ 45300
Last updated 14.19pm 16/04/2024 ?
BIT (ASX) Chart

Top Stories

Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold

Depending on what interests you more, there were two big stories this week for the international finance space.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.

Featured News

RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
FXG Market purrs with approval of Felix's 90% gold recovery in Alaska
right-arrow Created with Sketch.
NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
LU7 Lithium Universe shares jump on below-expected SPP result
right-arrow Created with Sketch.
OZM OzAurum Resources ups the ante on the charge for lithium in Brazi
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.